Lawyers: Superior Court Ignored SCOTUS in Reglan Ruling
The state Superior Court's decision not to apply blanket pre-emption to failure-to-warn claims against the makers of the generic version of acid reflux drug Reglan ignores U.S. Supreme Court precedent and makes Pennsylvania an outlier among the other states that have ruled on similar issues, some attorneys said.
This premium content is reserved for The Legal Intelligencer subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now